Welcome to the e-CCO Library!

P272: Faecal calprotectin and magnetic resonance imaging are highly accurate to detect endoscopic postoperative recurrence in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Baillet P.1, Cadiot G.2, Goutte M.3,4, Goutorbe F.3,5, Allimant C.3, Reymond M.3, Obritin H.3, Bommelaer G.3,4, Pereira B.6, Hordonneau C.1, Buisson A.*3,4

Created: Wednesday, 20 February 2019, 10:36 AM
P272: Predictors of health-related quality of life in patients with newly diagnosed moderate to severe ulcerative colitis: Results from the MOSAIC cohort in Korea
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y.M. Park1*, C.K. Lee1, S.N. Hong2, J.P. Im3, B.D. Ye4, J.M. Cha1, J.M. Cha1, S.-A. Jung5, K.-M. Lee6, D.I. Park7, Y.T. Jeen8, Y.S. Park9, J.H. Cheon10, H.-S. Kim11, Y. Kim11, H.J. Kim1

Created: Thursday, 21 February 2019, 9:14 AM
P272: Psychological burden in newly diagnosed IBD patients: Differences between Crohn's Disease and Ulcerative Colitis in early IBD
Year: 2022
Source: ECCO'22
Authors: Bernabeu, P.(1);Cameo, J.I.(2);Gutiérrez, A.(2);García, G.(3);García, M.F.(4);Aguas, M.(5);Belen, O.(2);Zapater, P.(6);Cabezos, P.(1);Andreu, A.(1);Jover, R.(2);van-der Hofstadt , C.(1);Ruiz, M.T.(7);Sempere, L.(2);
Created: Friday, 11 February 2022, 3:52 PM
P272: Reduced delay in diagnosis of Crohn's disease in patients presenting with perianal disease: results of a retrospective cohort study at a non-academic, IBD-expert centre in the Netherlands
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Munster, L.(1)*;de Groof, E.J.(1);van Dieren, S.(2);Mundt, M.W.(3);D'Haens, G.R.A.M.(4);Bemelman, W.A.(5);Buskens, C.J.(5);van der Bilt, J.D.W.(1);
Created: Friday, 14 July 2023, 11:05 AM
P272: Tofacitinib as salvage therapy for patients hospitalized with refractory severe active ulcerative colitis: a GETAID multicenter prospective/retrospective cohort
Year: 2021
Source: ECCO'21 Virtual
Authors: Uzzan, M.(1);Bresteau, C.(2);Laharie, D.(3);Stefanescu, C.(4);Carbonnel, F.(2);Serrero, M.(5);Viennot, S.(6);Nachury, M.(7);Amiot, A.(8);Altwegg, R.(9);Picon, L.(10);Nahon, S.(11);Vuitton, L.(12);Ah Soune, P.(13);Kirchgesner, J.(14);Peyrin-Biroulet, L.(15);Bouhnik, Y.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P273 Point-of-care bowel ultrasound for detecting ileocolonic inflammation in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Allocca1, G. Fiorino1, F. Furfaro1, A. Zilli1, D. Gilardi1, S. Radice1, L. Peyrin-Biroulet2, S. Danese1

Created: Thursday, 30 January 2020, 10:12 AM
P273: Efficacy and safety of upadacitinib maintenance treatment for moderate to severe Crohn’s disease: Results from the CELEST study
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Panes1*, W.J. Sandborn2, E.V. Loftus Jr.3, G. Van Assche4, S. Ghosh5, Q. Zhou6, S. Goteti6, J.V. Enejosa6, A.L. Pangan6, A.P. Lacerda6

Created: Thursday, 21 February 2019, 9:14 AM
P273: Inflammatory Bowel Disease and COVID-19 vaccine
Year: 2022
Source: ECCO'22
Authors: Zahra Bianco , E.(1);Tabone , T.(1);Cassar , P.(2);Agius , D.(2);Zammit , D.(2);Vella Baldacchino , A.(1);Scicluna , C.(1);Gatt , K.(1);Ciantar , M.(2);Montebello , B.(2);Ellul , P.(1);Sciberras , M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P273: Investigations of the characteristics and efficacy of anti-TNFα agents for optimising treatment in paediatric patients with new-onset Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Yokoyama*1, K. Watanabe1, K. Kojima2, R. Koshiba2, K. Fujimoto2, T. Sato1, M. Kawai2, K. Kamikozuru2, T. Takagawa2, T. Miyazaki2, N. Hida2, S. Nakamura2

Created: Friday, 22 February 2019, 9:41 AM
P273: Prediction of treatment response in Crohn's disease patients using contrast enhanced ultrasound: a pilot study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zezos P.*1, Atri M.2, Zittan E.3, Nazarian A.4, Steinhart A.H.1, Silverberg M.S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P273: Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H.-S. Lee*1, H. J. Lee1, H. Seo2, M. Seo2, E. M. Song2, S. W. Hwang2, S. H. Park2, D.-H. Yang2, K.-J. Kim2, B. D. Ye2, J.-S. Byeon2, S.-J. Myung2, S.-K. Yang2

Created: Friday, 22 February 2019, 9:49 AM
P273: Severity of colitis and clinical outcomes for patients admitted with acute UC in 2 large UK centres
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Al Sulais, E.(1)*;Mukhtar, M.S.H.(2);Parkes, G.(3);Hart, A.(4);Raine , T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P273: The duration of clinical remission in patients with Crohn's disease depends on the frequency of administration of mesenchymal stromal cells of the bone marrow
Year: 2021
Source: ECCO'21 Virtual
Authors: Knyazev, O.(1,2,3);Kagramanova, A.V.(1);Lishchinskaya, A.(1);Li, I.(1);Shkurko, T.(2);Veselov, A.(2);Fadeeva, N.(4);Zhulina, E.(4);Parfenov, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P274 The clinical significance of anastomotic ulcers after ileocolic resection to predict postoperative recurrence of Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.Y. Kim1, S.H. Park1, Y.J. Kim2, J.C. Park1, S. Noh1, J.S. Lee1, J. Kim1, N.S. Ham1, E.H. Oh1, S.W. Hwang1, D.H. Yang1, B.D. Ye1, J.S. Byeon1, S.J. Myung1, S.K. Yang1

Created: Thursday, 30 January 2020, 10:12 AM
P274: Assessing the individual risk of acute severe colitis at diagnosis in a South Asian population
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Powles S., Chong L., Hicks L., Han L., Omassoli J., Williams H., Orchard T.

Created: Wednesday, 20 February 2019, 10:36 AM
P274: Bioelectrical impedance analysis identifies low skeletal muscle index in patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Nguyen, A.(1);Holt, D.(2);Burns, M.(2);Herath, M.(3);Gibson, P.R.(4);Ebeling, P.(5);Milat, F.(3);Moore, G.(6);
Created: Friday, 11 February 2022, 3:52 PM
P274: Clinical manifestations, risk factors and prognostic factors of Cytomegalovirus Colitis in Inflammatory Bowel Disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hsieh, C.R.(1)*;Le, P.H.(2);Kuo, C.J.(2);Yeh , P.J.(3);Chiu, C.T.(2);
Created: Friday, 14 July 2023, 11:05 AM
P274: Drug utilization of biologic therapy in Crohn’s disease and ulcerative colitis: A population based Danish cohort study 2015-2018
Year: 2021
Source: ECCO'21 Virtual
Authors: Jensen, K.(1);Jensen, C.B.(1);Wennerström, C.(2);Sommer, K.J.(3);Burisch, J.(4);Petersen, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P274: Factors driving treatment escalation in Crohn’s disease in the CALM trial
Year: 2018
Source: ECCO '18 Vienna
Authors:

W. Reinisch1*, R. Panaccione2, P. Bossuyt3, F. Baert4, A. Armuzzi5, X. Hebuterne6,7, S. Danese8, W.J. Sandborn9, S. Schreiber10, G. D'Haens11, S. Berg12, Q. Zhou13, J. Petersson13, E. Neimark13, A.M. Robinson13, J.-F. Colombel14

Created: Thursday, 21 February 2019, 9:14 AM
P274: Malignancy in perianal Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. Ficari*1, S. Scaringi1, F. Giudici1, D. Zambonin1, C. Di Martino1, F. Tonelli2, P. Bechi1

Created: Friday, 22 February 2019, 9:49 AM